Postdoctoral Research Fellow

University of Oklahoma Health Campus; Oklahoma City (OK); In loco; USD 52.000 - 90.000; Tempo pieno

Descrizione del lavoro

The Kamiya Mehla lab at the University of Oklahoma Harold Hamm Health Campus, in the OU Health Stephenson Cancer Center, is recruiting a postdoctoral researcher to study cancer immunometabolism and tumor-immune interactions in pancreatic cancer using multidisciplinary approaches. Applicants should hold a Ph.D.

or MD/PhD in Immunology, Molecular Biology, or Cancer Biology, with experience in flow cytometry, cell-based assays, and/or animal studies.

Competenze

• PhD or MD/PhD in Immunology, Molecular Biology, or Cancer Biology.
• Experience with flow cytometry, cell-based assays, and/or animal studies.
• Strong publication record and ability to work in a multidisciplinary team.

Mansioni

• Study cancer immunometabolism and tumor-immune interactions in pancreatic cancer.
• Work with multi-omics approaches including scRNA-seq and bulk RNA-seq.
• Contribute to NIH/NCI-funded study in a collaborative laboratory environment.

Conoscenze

Flow cytometry

Cell-based assays

Animal studies

Formazione

PhD

MD/PhD

Strumenti

CRISPR screens

Organoid models

scRNA-seq

Mouse models

Descrizione del lavoro

Postdoctoral Research Fellow

University of Oklahoma Harold Hamm Health Campus

The Kamiya Mehla lab in the Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting a postdoctoral researcher to join an NIH/NCI-funded study on cancer immunotherapy and immunometabolism. The postdoctoral researcher will be working in a multidisciplinary research group to study novel aspects of immunometabolism, tumor-immune cell interactions at the primary tumor and systemic sites in pancreatic cancer. Our state-of-the art research program utilizes molecular biology and immunology techniques along with multi-omics approaches, including sc-RNA-seq, bulk RNAseq, epigenomics, metabolomics, proteomics, CRISPR screens and genetically engineered mouse models and organoid models of pancreatic cancer.

The ideal candidate should possess a Ph.D or M.D./Ph.D in the field of Immunology/ Molecular Biology/ and Cancer Biology with expertise in flow cytometry, cell-based assays, and/or animal studies. For more detail, please refer to our recent articles (Cancer Discovery, 2024, Molecular Cancer, 2026, Nature Cell Biology, 2024, Oncogene. 2022, Trends Immunol. 2022, Gastroenterology 2021, JEM 2020). The Mehla Lab offers a friendly, supportive, and collaborative environment with great excitement for cancer research. Ourfuture research objectives include, but are not limited to, cell-based therapeutics.

The University, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, marital status, genetic information, gender identity/expression (consistent with applicable law), age (40 or older), religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes but is not limited to admissions, employment, housing, financial aid, and educational services.